Life Science REIT PLC (LABS)

Category Property - Direct UK


Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

46.00p

Buy

46.30p

arrow-down-0.10p (-0.22%)

Discount/Premium

-39.31%

Estimated NAV

75.796p

Prices updated at 28 Mar 2025, 16:53 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

arrow-down-0.11%
LSE

Company name
Ironstone Asset Management Limited
Legal structure
Closed Ended Investment Company
Domicile
United Kingdom
Fiscal year end
31 Dec 2025
Launch date
19 Nov 2021
Fund manager
Stephen Barrow
Manager start date
19 Nov 2021
Fund manager biography
Head office
C/O Hillier Hopkins,First Floor Radius House, 51 Clarendon Road
Watford
United Kingdom
WD17 1HP
mobile
-
letter
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.